In the fall edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2021, a marriage nearly tears apart a certified class, insurers are vaccinated against more COVID-19 suits, and ERISA shifts the burden of proof. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Class Action & MDL Roundup
Fall 2021
Class Action & MDL Roundup – Fall 2021
-
Cari K. Dawson
-
David Venderbush
-
Ryan P. Ethridge
-
Alexander Akerman
-
Charlotte M. Bohn
-
David Carpenter
-
F. Nicholas Chandler
-
R. Blake Crohan
-
Jamie S. George
-
Bradley Harder
-
Kara F. Kennedy
-
Matthew D. Lawson
-
Andrew J. Liebler
-
Melissa Quintana
-
William J. Repko III
-
Jason Rottner
-
Troy A. Stram
-
Andrew T. Sumner
-
Amanda M. Waide
Meet the Authors
Related News & Insights
-
Class Action & MDL Roundup September 29, 2025Class Action & MDL Roundup | 2025 Q2 | Exceeding Every Standard
In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2025, the Supreme Court lowers its standards (in ERISA suits), one circuit changes its standards (for personal jurisdiction), and another circuit toughens up its standards (for class certification). Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup October 2, 2024Class Action & MDL Roundup 2024 Q2 – We are administratively feasibleIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2024, there can be only one claim form for many, broiler chickens are coming home to roost, and there is no conspiracy of memes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup December 18, 2023Class Action & MDL Roundup 2023 Q3 - Catching the class action waive(r)In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2023, a mistake is just a mistake, “99.99%” isn’t 100% clear, and faxes aren’t always free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup September 29, 2023Class Action & MDL Roundup 2023 Q2 – Ascertainability lives!In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2023, essential oils may need therapy, an ever-growing library goes nowhere, and one exclusion is specifically ambiguous. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact
Related Services & Industries
